Stocks Comparison
Glass House Brands vs Niagen Bioscience: revenue, profit, margins and growth compared
Glass House Brands brought in $182M of revenue in fiscal 2025, Niagen Bioscience $129.4M in fiscal 2025. Revenue changed by -9.4% at Glass House Brands and +29.9% at Niagen Bioscience on the year before, so Niagen Bioscience grew faster. Glass House Brands kept -16.3% of its revenue as net profit, Niagen Bioscience 13.4%.
Side by side, latest fiscal year
| GLAS | NAGE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $182M | $129.4M |
| Revenue growth | -9.4% | +29.9% |
| Net income | -$29.7M | $17.4M |
| Net margin | -16.3% | 13.4% |
| Free cash flow | -$15.7M | n/a |
| Free cash flow margin | -8.6% | n/a |
| Earnings per share (diluted) | -$0.55 | $0.20 |
| Cash | $23.4M | $64.8M |
| Debt | $68.7M | n/a |
| Price to earnings | n/a | 15.3 |
| Market value | $598.4M | $241.3M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #261 of 523 · Health care | #282 of 523 · Health care |
Over the years
Questions about Glass House Brands and Niagen Bioscience
Which is bigger by revenue, Glass House Brands or Niagen Bioscience?
Glass House Brands is bigger by revenue: $182M in fiscal 2025, against $129.4M for Niagen Bioscience in fiscal 2025.
Which keeps more of its revenue as profit, Glass House Brands or Niagen Bioscience?
Glass House Brands had a net margin of -16.3% in fiscal 2025; Niagen Bioscience had 13.4% in fiscal 2025.
Which grew revenue faster, Glass House Brands or Niagen Bioscience?
In their latest fiscal years revenue changed by -9.4% at Glass House Brands and +29.9% at Niagen Bioscience.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.